Document Detail


When betamethasone and dexamethasone are unavailable: hydrocortisone.
MedLine Citation:
PMID:  11894514     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To review the literature on alternatives to betamethasone and dexamethasone for enhancement of fetal lung maturity. STUDY DESIGN: A medline search was conducted from 1966 to the present. Trials dealing with enhancement of fetal lung maturity using modalities other than betamethasone or dexamethasone were reviewed. RESULTS: Eight studies met inclusion criteria. Excluding betamethasone and dexamethasone, the most frequently studied glucocorticoids, for fetal lung maturation, are methylprednisolone and hydrocortisone. Methylprednisolone does not cross the placenta. Two grams of hydrocortisone has been shown to improve indices of fetal lung maturity (i.e., L/S ratio) and to improve fetal outcomes compared to no treatment. CONCLUSION: There is limited information about alternatives to betamethasone and dexamethasone for the enhancement of fetal lung maturity in women at risk of preterm delivery. In the absence of these two preferred drugs, hydrocortisone can be given at a dose of 500 mg intravenously every 12 hours for four doses for this indication.
Authors:
L E Moore; J N Martin
Related Documents :
10385594 - Lung growth response after tracheal occlusion in fetal rabbits is gestational age-depen...
3420324 - Fetal lung growth: influence of maternal hypoxia and hyperoxia in rats.
16462584 - Low oxygen saturation by pulse oximetry may be associated with a low oxygen affinity he...
181834 - Effect of cortisone and acth on the phospholipids of human amniotic fluid and lung tiss...
2565314 - Empirical therapy of the male with clomiphene in couples with unexplained infertility.
23804814 - Pregnancy in patients with tetralogy of fallot: outcome and management.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Journal of perinatology : official journal of the California Perinatal Association     Volume:  21     ISSN:  0743-8346     ISO Abbreviation:  J Perinatol     Publication Date:    2001 Oct-Nov
Date Detail:
Created Date:  2002-03-15     Completed Date:  2002-04-05     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8501884     Medline TA:  J Perinatol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  456-8     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, University of Mississippi Medical Center, 2500 North State Street, Jackson, MS 39216-4505, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anti-Inflammatory Agents / therapeutic use*
Betamethasone / therapeutic use*
Dexamethasone / therapeutic use*
Female
Humans
Hydrocortisone / therapeutic use*
Infant, Newborn
Infant, Premature, Diseases / prevention & control*
Lung / drug effects*,  embryology*
Lung Diseases / embryology*,  prevention & control*
Pregnancy
Chemical
Reg. No./Substance:
0/Anti-Inflammatory Agents; 378-44-9/Betamethasone; 50-02-2/Dexamethasone; 50-23-7/Hydrocortisone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  When combined, early bedside head ultrasound and electroencephalography predict abnormal computerize...
Next Document:  Central venous catheter tip in the right atrium: a risk factor for neonatal cardiac tamponade.